Objective To synthesize findings from recent studies of strategies to deliver insecticide-treated nets (ITNs) at scale in malaria-endemic areas.
Introduction
Malaria continues to represent a major public health problem in areas of endemicity, with an estimated 225 million cases worldwide in 2009. 1 The 2015 goals of the World Health Organization's (WHO's) Roll Back Malaria Partnership are to reduce global malaria cases by 75% from 2000 levels and to reduce malaria deaths to near zero through universal coverage by effective prevention and treatment interventions. 1 Among other preventive interventions, WHO recommends the use of insecticide-treated nets (ITNs), particularly long-lasting insecticidal nets, which have been shown to be cost-effective, [2] [3] [4] to reduce malaria episodes among children < 5 years of age (hereafter, "children under 5") by approximately 50% and all-cause mortality by 17%. 5, 6 Universal coverage with ITNs is defined as use by > 80% of individuals in populations at risk. 6 WHO recommends supplying ITNs without charge or with a high subsidy and using a combination of periodic mass campaigns and routine delivery channels to deliver ITNs at scale. 6 Other strategies include supporting the existing commercial sector and distributing vouchers exchangeable for partially subsidized ITNs through retailers. 
Methods
A systematic review was conducted to identify studies that reported on the delivery of ITNs (including long-lasting insecticidal nets) at scale. The findings reported here form part of a larger systematic review on the scale up of WHO-recommended malaria control interventions. 8 We used a definition of "scaling up" that characterized this activity as the expansion of a health intervention beyond the initial geographical area or population group covered. 9, 10 We considered "at scale" to be ITN delivery in at least one district or the equivalent lowest level of health service administration in a given country.
Search strategy
Medline (Ovid), EMBASE, CAB Abstracts, Global Health and Africa Wide databases were searched using subject heading classification terms and free-text words. The following categories were combined using the AND Boolean logic operator: malaria terms, ITN and long-lasting insecticidal net terms and scaling-up terms (Box 1, available at:
http://www.who.int/bulletin/volumes/90/9/11-094771). Filters were used to limit the search to humans and to publication dates from January 2000 through December 2010. Relevant papers from the grey literature were identified by searching Eldis and WHOLIS databases and Roll Back Malaria, Malaria Consortium, Africa Malaria Network Trust, and The Global
Fund to Fight AIDS, Tuberculosis and Malaria web sites. Citation data for identified papers were exported to EndNote (Thomson Reuters, Carlsbad, USA), where duplicates were removed.
Eligibility criteria
Screening was a two-stage process. First, two authors (BW and LSP) independently screened titles and abstracts to determine which papers should undergo full-text assessment for eligibility. Retained papers underwent full-text review (performed independently by BW and LSP) to determine whether they described studies that satisfied the following criteria:
subjects resided in areas where Plasmodium falciparum and Plasmodium vivax are endemic;
ITN delivery at scale was evaluated; ITN ownership among households, receipt by pregnant women and/or use among children under 5 was evaluated; and an individual or clusterrandomized controlled design, a nonrandomized design, a quasi-experimental design, a before-and-after design, an interrupted time series design or a cross-sectional design without temporal or geographical controls was used. [11] [12] [13] Papers meeting these criteria were termed "index papers." In addition to documenting and characterizing the strategies for delivering
ITNs at scale and summarizing ITN ownership among households and ITN use among children under 5, this review also aimed to summarize the reported cost or cost-effectiveness of different strategies and to synthesize information on reported factors influencing delivery of ITNs at scale. As such, we also included papers that described qualitative studies, case studies, process evaluations and cost-effectiveness studies that were linked to an index paper.
The reference lists from eligible papers were hand-searched for additional relevant citations. All data relevant to the review were extracted from final included papers into an Access database (Microsoft, Redmond, United States of America).
Analysis
The first objective was to document and characterize the strategies for delivering ITNs at scale and was guided by a framework adapted from Kilian et al. 14 Strategies were characterized by target population, implementation scale, implementer type, user cost and implementation duration (Fig. 1 ).
The effectiveness of ITN delivery strategies was not compared using meta-analysis because study designs were too variable. 11 Rather, narrative synthesis with a Best Evidence Synthesis approach was used to summarize findings and compare results across the different delivery strategies.
15,16
The extent to which ITN ownership or use changed over time and whether such changes were attributable to the delivery strategy were assessed according to study quality.
The quality of studies with a randomized or nonrandomized control group and of those using an interrupted time-series design was assessed using the Cochrane risk of bias checklist 11 and
Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Content analysis and narrative synthesis were used to identify important influences on delivering ITNs at scale and themes were assessed across the different ITN delivery strategies.
Results Group. 18 We included 32 papers that described 20 studies from 12 African nations (Burkina Faso, Eritrea, Ghana, Kenya, Madagascar, Malawi, Niger, Nigeria, United Republic of Tanzania, Togo, Uganda and Zambia) and one partially autonomous region (Zanzibar). Six studies were implemented on a national level, two on a regional scale and 12 at the district level (of which three took place in only one district). Fourteen studies delivered ITNs only to children under 5 and/or pregnant women (Table 1 and Table 2 , both available at:
http://www.who.int/bulletin/volumes/90/9/11-094771). 
Strategies for delivering ITNs at scale

Equity of ITN ownership and use
Thirteen studies reported coverage stratified according to socioeconomic status as a measure of equity (Table 2) . One study evaluated equity on the basis of urban and rural residence and twelve studies evaluated it on the basis of a household asset index. Of the latter studies, three The study that evaluated equity in terms of urban and rural residence was based on data from a national survey performed after partially subsidized delivery of ITNs to pregnant women and children under five at health centres. 26 The survey found greater use among children under 5 in urban areas, compared with those in rural areas (51% versus 17% In the fourth study, the delivery of partially subsidized ITNs to pregnant women via antenatal care clinics in the United Republic of Tanzania was examined. [29] [30] [31] [32] The fifth study reviewed a stand-alone ITN campaign involving distribution of fully subsidized nets to children under 5
in the Micheweni district of Zanzibar. between survey years varies by study design and delivery strategy.
33
Study quality
Only the cluster-randomized controlled trial directly compared different delivery strategies. 21, 22, 44 One strategy involved subsidized sale, promoted by social marketing, of
ITNs to the general population plus free distribution of long-lasting insecticidal nets to pregnant women at antenatal care clinics. The other strategy involved only subsidized sale, promoted by social marketing, of ITNs to the general population through retailers. Ownership of ITNs was 35% in the dual-intervention arm and 23% in the retail-only arm (P < 0.001).
Although the risk of bias was low in this study, the quality of the evidence was downgraded from high to moderate on the basis of the GRADE criteria because it was unclear whether analyses adjusted for the clustered design and because no relative measure of effect was provided.
One study described the delivery of partially subsidized ITNs at the district level through sales by health facility staff. 25 ITN ownership was 14% in three intervention districts, compared with 1.3% in two comparison districts (P < 0.001). The risk of bias in this study was moderate principally because of the lack of randomization. The quality of evidence was very low on the basis of the GRADE criteria because there were important differences between intervention and comparison areas at baseline (e.g. socioeconomic status) that were not adjusted for in the analysis and because no relative measure of effect was provided.
In nonrandomized studies, identification of the channel through which the ITN is delivered (i.e. antenatal clinics or retail shops) may help determine whether the change in coverage achieved can be allocated to the delivery strategy. 12 Studies in three countries did not stratify ITN ownership by delivery channel. 
Costs
Ten studies reported on the cost or cost-effectiveness of ITNs (Table 3) . Of these, seven described only cost per ITN delivered or cost per treated-net-year. The remaining three were cost-effectiveness studies that also presented cost per death or per disability-adjusted life year averted. All except one of the economic evaluation studies conducted sensitivity analyses around the major cost and outcome parameters. The four studies that evaluated fully subsidized campaigns found financial costs per ITN delivered of US$ 3.71 to US$ 11.79 for those integrated with vaccination campaigns 20,37,40 and US$ 9.48 for a stand-alone campaign. 24 The stand-alone campaign considered in one of the studies had an economic cost per ITN delivered of US$ 4.76.
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Three studies presented some measure of health impact. The economic cost per child death averted was US$ 1242 for a national voucher scheme 32 and US$ 2924 in for a retail sector programme involving partially subsidized delivery. 45 The economic cost per disabilityadjusted life year averted was similar, at US$ 100 and US$ 107.
23,45
Cost or cost-effectiveness estimates were most sensitive to the assumed ITN lifespan (i.e. physical viability and duration of insecticide protection) and the proportion of ITNs actually used (leakage). The main cost associated with ITN delivery programmes was the ITNs themselves, most often followed by staff and transport.
Factors influencing ITN delivery
Information on factors influencing delivery of ITNs at scale was available for 12 of 20 studies (Table 4) . Important perceived influences on the delivery of ITNs at scale, from the perspective of actors involved, were categorised into those at the user level, the implementer or health system level and the policy level. This review aimed to synthesize details on the context of, barriers to and facilitators of strategies to deliver ITNs at scale, some of which were implemented under nearprogrammatic conditions. Important factors influencing the delivery of ITNs at scale were similar across delivery strategies. Barriers involving cost were common at the user level, whereas barriers involving stockouts and poor logistics for ITN procurement and transport were common at the implementer level. Training and supervision of staff was often highlighted as a facilitator at the implementer level and cooperation across departments or ministries and stakeholder involvement were highlighted at the policy level.
The evaluation of large-scale health programmes has been highlighted as a "top priority in global health" 52 and researchers have emphasized that the use of randomized designs for such evaluation may be inappropriate because of low external validity.
11,53
Therefore, to characterize the full breadth of ITN delivery strategies and to synthesize evidence that corresponded to the conditions under which large-scale ITN delivery may occur in practice, we included a variety of study designs. 54 However, this made interpretation of findings challenging, particularly because a before-and-after study of a campaign conducted at a single time point is qualitatively different from annual surveys conducted during a continuous distribution strategy.
The Medical Research Council recommends that the evaluation of complex interventions include information on the context and implementation of interventions. Our experience in conducting this review suggests that future synthesis of evidence involving large-scale delivery of complex public health interventions would benefit from improved consistency of reporting of the implementation process by included studies. 55, 56 Recommendations for reporting are available from the Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) statement. 57 It is simplistic to interpret the findings of this review as providing a single recommendation to policy-makers on which ITN delivery strategy to adopt. Rather, the review highlights that choosing among alternatives depends on contextual factors, such as the epidemiologic characteristics of malaria, attributes of health systems and contextual constraints. Moreover, the review demonstrates how a framework for characterizing delivery strategies can prove useful in synthesizing evidence, which may help policy-makers formulate implementation strategies to deliver ITNs to populations in their local settings. GP, general population; LLIN, long-lasting insecticidal nets; MDA, mass drug administration; PW, pregnant women.
a Studies may appear in more than one category if multiple strategies were used to deliver ITNs at scale or if strategies changed over time.
b Used voucher-based distribution of partially subsidised ITNs, in which vouchers were distributed in antenatal care clinics and exchanged for a partially subsidised ITN in retail outlets. e Denominators for households and children under 5 are equal because the index child (i.e. youngest child in household who was aged ≥ 6 months at time of the campaign) was included in the calculation. 
